Intravenous glutamine in ICU patients: Clinical evidence and mechanisms of action;Supplémentation parentérale en glutamine en réanimation : preuves cliniques et mécanismes d'action

Reanimation

Volumn 18, Issue 6, 2009, Pages 506-510

  Coeffier M ^a,b   Tamion, F ^b,c   Dechelotte P ^a,b  

^a Faculté de Médecine Pharmacie   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Glutamine; ICU; Infectious complications; Inflammatory response; Oxidative stress

Indexed keywords

ANTIOXIDANT; GLUTAMINE; HEAT SHOCK PROTEIN; TRACE ELEMENT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CELL PROTECTION; CRITICALLY ILL PATIENT; DRUG MECHANISM; GLUCOSE METABOLISM; HOSPITAL INFECTION; HUMAN; IMMUNOMODULATION; INFECTIOUS COMPLICATION; INTENSIVE CARE; INTESTINE MUCOSA PERMEABILITY; LENGTH OF STAY; OXIDATIVE STRESS; PARENTERAL NUTRITION; PROTEIN EXPRESSION; SHORT SURVEY; SURVIVAL TIME;

EID: 69049090724     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2009.05.016     Document Type: Short Survey

References (43)

1. Oudemans-van Straaten H.M., Bosman R.J., Treskes M., van der Spoel H.J., and Zandstra D.F. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 27 (2001) 84-90
2. Souba W.W. Nutritional support. N Engl J Med 336 (1997) 41-48
3. Karinch A.M., Pan M., Lin C.M., Strange R., and Souba W.W. Glutamine metabolism in sepsis and infection. J Nutr 131 (2001) [2535S-8S; discussion 2550S-1S]
4. http://www.criticalcarenutrition.com (site consulté en avril 2009).
5. Labow B.I., and Souba W.W. Glutamine. World J Surg 24 (2000) 1503-1513
6. Hong R.W., Rounds J.D., Helton W.S., Robinson M.K., and Wilmore D.W. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 215 (1992) 114-119
7. Belmonte L., Coeffier M., Le Pessot F., et al. Effects of glutamine supplementation on gut barrier, glutathione content and acute phase response in malnourished rats during inflammatory shock. World J Gastroenterol 13 (2007) 2833-2840
8. Coeffier M., Claeyssens S., Hecketsweiler B., Lavoinne A., Ducrotte P., and Dechelotte P. Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa. Am J Physiol Gastrointest Liver Physiol 285 (2003) G266-G273
9. Rhoads J.M., Argenzio R.A., Chen W., et al. L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol 272 (1997) G943-G953
10. Calder P.C., and Yaqoob P. Glutamine and the immune system. Amino Acids 17 (1999) 227-241
11. Griffiths R.D., Jones C., and Palmer T.E. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13 (1997) 295-302
12. Goeters C., Wenn A., Mertes N., et al. Parenteral l-alanyl-l-glutamine improves 6-months outcome in critically ill patients. Crit Care Med 30 (2002) 2032-2037
13. Griffiths R.D., Allen K.D., Andrews F.J., and Jones C. Infection, multiple organ failure and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition 18 (2002) 546-552
14. Wischmeyer P.E., Lynch J., Liedel J., et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 29 (2001) 2075-2080
15. Fuentes-Orozco C., Anaya-Prado R., Gonzalez-Ojeda A., et al. l-alanyl-l-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr 23 (2004) 13-21
16. de Beaux A.C., O'Riordain M.G., Ross J.A., Jodozi L., Carter D.C., and Fearon K.C. Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition 14 (1998) 261-265
17. Ockenga J., Borchert K., Rifai K., Manns M.P., and Bischoff S.C. Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis. Clin Nutr 21 (2002) 409-416
18. Fuentes-Orozco C., Cervantes-Guevara G., Mucino-Hernandez I., et al. l-alanyl-l-glutamine-supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr 32 (2008) 403-411
19. Xian-li H., Qing-jiu M., Jian-guo J., Yan-kui C., and Xi-lin D. Effect of total parenteral nutrition (TPN) with and without glutamine dipeptide supplementation on outcome in severe acute pancreatitis (SAP). Clin Nutr Suppl 1 (2004) 43-47
20. Dechelotte P., Hasselmann M., Cynober L., et al. l-alanyl-l-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 34 (2006) 598-604
21. Borel M.J., Williams P.E., Jabbour K., Levenhagen D., Kaizer E., and Flakoll P.J. Parenteral glutamine infusion alters insulin-mediated glucose metabolism. JPEN J Parenter Enteral Nutr 22 (1998) 280-285
22. Bakalar B., Duska F., Pachl J., et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 34 (2006) 381-386
23. Wischmeyer P.E. Glutamine: role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol 24 (2008) 190-197
24. De-Souza D.A., and Greene L.J. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med 33 (2005) 1125-1135
25. Evans M.E., Jones D.P., and Ziegler T.R. Glutamine prevents cytokine-induced apoptosis in human colonic epithelial cells. J Nutr 133 (2003) 3065-3071
26. Le Bacquer O., Laboisse C., and Darmaun D. Glutamine preserves protein synthesis and paracellular permeability in Caco-2 cells submitted to "luminal fasting". Am J Physiol Gastrointest Liver Physiol 285 (2003) G128-G136
27. Li N., Lewis P., Samuelson D., Liboni K., and Neu J. Glutamine regulates Caco-2 cell tight junction proteins. Am J Physiol Gastrointest Liver Physiol 287 (2004) G726-G733
28. van der Hulst R.R., van Kreel B.K., von Meyenfeldt M.F., et al. Glutamine and the preservation of gut integrity. Lancet 341 (1993) 1363-1365
29. Zhou Y.P., Jiang Z.M., Sun Y.H., Wang X.R., Ma E.L., and Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr 27 (2003) 241-245
30. Flaring U.B., Rooyackers O.E., Wernerman J., and Hammarqvist F. Glutamine attenuates posttraumatic glutathione depletion in human muscle. Clin Sci (Lond) 104 (2003) 275-282
31. Boelens P.G., Houdijk A.P., Fonk J.C., et al. Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients. J Nutr 132 (2002) 2580-2586
32. Manhart N., Vierlinger K., Spittler A., Bergmeister H., Sautner T., and Roth E. Oral feeding with glutamine prevents lymphocyte and glutathione depletion of Peyer's patches in endotoxemic mice. Ann Surg 234 (2001) 92-97
33. Kudsk K.A., Wu Y., Fukatsu K., et al. Glutamine-enriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels. JPEN J Parenter Enteral Nutr 24 (2000) 270-274 discussion 274-5
34. Marion R., Coeffier M.M., Gargala G., Ducrotte P., and Dechelotte P.P. Glutamine and CXC chemokines IL-8, Mig, IP-10 and I-TAC in human intestinal epithelial cells. Clin Nutr 23 (2004) 579-585
35. Coeffier M., Marion R., Ducrotte P., and Dechelotte P. Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clin Nutr 22 (2003) 407-413
36. Fukatsu K., Kudsk K.A., Zarzaur B.L., Wu Y., Hanna M.K., and DeWitt R.C. TPN decreases IL-4 and IL-10 mRNA expression in lipopolysaccharide stimulated intestinal lamina propria cells but glutamine supplementation preserves the expression. Shock 15 (2001) 318-322
37. Uehara K., Takahashi T., Fujii H., et al. The lower intestinal tract-specific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury. Crit Care Med 33 (2005) 381-390
38. Hubert-Buron A., Leblond J., Jacquot A., Ducrotte P., Dechelotte P., and Coeffier M. Glutamine pretreatment reduces IL-8 production in human intestinal epithelial cells by limiting IkappaBalpha ubiquitination. J Nutr 136 (2006) 1461-1465
39. Singleton K.D., Beckey V.E., and Wischmeyer P.E. Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release and prevents acute respiratory distress syndrom (ARDS) following sepsis. Shock 24 (2005) 583-589
40. Ziegler T.R., Ogden L.G., Singleton K.D., et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 31 (2005) 1079-1086
41. Wischmeyer P.E. Glutamine and heat shock protein expression. Nutrition 18 (2002) 225-228
42. Singleton K.D., and Wischmeyer P.E. Effects of HSP70. 1/3 gene knock-out on acute respiratory distress syndrome and the inflammatory response following sepsis. Am J Physiol Lung Cell Mol Physiol 290 (2006) L956-61
43. Heyland D.K., Dhaliwal R., Day A.G., Muscedere J., Drover J., Suchner U., et al., Canadian Critical Care Trials Group. Reducing deaths due to oxidative stress (The REDOXS Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 65 (2006) 250-263